Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03624036 |
|---|---|
| Brief Title: | Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ZUMA-8) |
| First Submitted : | August 7, 2018 |
| First Submitted that Met QC Criteria : | August 7, 2018 |
| First Posted : | August 9, 2018 |
| Results First Submitted : | February 14, 2022 |
| Results First Submitted that Met QC Criteria : | May 6, 2022 |
| Results First Posted : | May 10, 2022 |
| Last Update Submitted that Met QC Criteria : | October 31, 2023 |
| Last Update Posted : | November 18, 2023 |